Skip to main content
Table of Contents
Print

What Future Research Is Needed to Understand Cannabis’s Role In RLS? 

Author: Dr. Clarissa Morton, PharmD

Although cannabis is increasingly being explored for managing Restless Legs Syndrome (RLS), the science is still in its early stages. There is a pressing need for future research on cannabis for RLS can build on, especially to move from anecdotal evidence to rigorous, clinically proven outcomes. 

At present, most data come from small studies or patient reports. For cannabis to earn its place as a credible treatment for RLS, focused future research on cannabis for RLS efforts is essential. 

What Gaps Should Research Address? 

Here are three areas where the evidence must grow: 

Larger, controlled RCTs 

Randomised controlled trials (RCTs) are needed to establish efficacy and control for placebo effects. These studies would offer much-needed clarity on which types of cannabis work best and in what dosages. 

Long-term safety monitoring 

We still know little about the risks of prolonged use, particularly in older adults or patients taking other medications. Studies must examine long-term safety to determine whether benefits continue over time without adverse consequences. 

Dosing guidelines and consistency 

Because cannabis products vary so widely in strength and composition, standardised dosing strategies are needed. Consistent dosing protocols would help clinicians guide patients more effectively. 

Until this future research on cannabis for RLS needs are met, cannabis remains a promising but experimental option in the RLS toolkit. 

Visit providers like LeafEase to stay informed about the latest research efforts and explore current treatment options supported by growing scientific interest. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Restless Legs Syndrome.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories